HPLC法测定不同产地黑丹皮中丹皮酚的含量

为建立黑丹皮药材中丹皮酚含量测定方法。采用菲罗门LunaC18(4.6 mm×250 mm,5μm)色谱柱,以甲醇-水(45∶55)为流动相,流速1.0 mL/min,检测波长274 nm。经测定丹皮酚含量在0.0432～0.324 ug范围内呈良好的线性关系(r=0.9999);平均回收率为104.07%,RSD=2.22%。该方法简便、准确、重现性好,适用于黑丹皮的质量控制。     

HPLC法对舒新片中丹皮酚的含量测定

目的:建立舒新片中丹皮酚的含量测定方法.方法:用高效液相色谱法对舒新片中丹皮酚进行定量分析,色谱柱为Kromsal C18柱(250 mm× 4.6 mm,5μm);流动相为甲醇-水(60∶40);流速:1.0mL/min;检测波长274nm.结果:丹皮酚在0.021～0.105mg/ml范围内线性关系良好,r=0.9997;平均加样回收率为99.07％,RSD为0.36％.结论:该方法简单、准确、专属性强、重复性好,可有效控制舒新片中丹皮酚的含量.     

HPLC测定双金花茶中免疫活性分子山奈酚的含量

目的建立HPLC测定双金花茶中免疫活性分子山奈酚含量的方法。方法采用Kromasil C18(4.6 mm×200 mm,5μm)色谱柱;流动相:甲醇∶0.1%醋酸水溶液(70∶30);流速:1.0 ml/min;检测波长:370 nm;柱温:25℃。结果山奈酚在进样量0.04～0.40μg(r=0.9999)范围内呈良好线性关系,平均加样回收率为100.00%,RSD为0.07%(n=6)。结论 HPLC法简便易行,准确可靠,可用于双金花茶中免疫活性分子山奈酚含量测定。     

高效液相色谱法测定降糖1号胶囊中淫羊藿苷的含量

目的:建立测定降糖1号胶囊中淫羊藿苷含量的方法。方法:室温条件下超声提取降糖1号胶囊中的淫羊藿苷,用D101大孔吸附树脂柱纯化提取物,高效液相色谱法(HPLC)测定含量,色谱柱:Hypersil ODS2(4.6mm×200mm,5μm);流动相:乙腈-水(30:70);流速:1ml/min,检测波长270nm;柱温:30℃。结果:淫羊藿苷的进样量在0.08μg-0.28μg范围内线性关系良好(r=0.9999),平均加样回收率(n=6)为96.66%,RSD为2.14%。结论:该方法简便、准确、重复性好,可用于降糖1号胶囊的质量控制。     

RP-HPLC法测定北柴胡地上部分山柰酚的含量

目的:建立RP-HPLC法测定北柴胡地上部分山柰酚含量的色谱方法。方法:采用RP-HPLC,C18柱(150 mm×4.6 mm,5μm),流动相甲醇-(0.5%磷酸)水(体积比为48∶52),检测波长360 nm,柱温34℃。结果:山柰酚质量浓度在0~0.048 g/L内与峰面积呈良好的线性关系,r=0.999 5(n=6);平均回收率为100.7%,RSD=1.8%(n=6)。结论:测定方法准确,可靠,为北柴胡地上部分的质量评价提供了可靠的依据。     

HPLC法测定腰痹通胶囊中三七总皂苷的含量

目的:建立HPLC测定腰痹通胶囊中三七总皂苷的含量测定方法。方法:采用高效液相色谱法,Kromasil C18(250mm×4.6mm,5μm)色谱柱,流动相为乙腈-水,梯度洗脱,流速1.0ml·min-1,柱温30℃,检测波长为203nm。结果:人参皂苷Rg1在1.4073μg~14.073μg范围内,呈良好的线性关系(r=0.9998),回收率为96.4%,RSD为1.7%。结论:本方法快速、准确,重复性良好,可作为腰痹通胶囊的质量分析控制方法。     

壮、瑶药小槐花中异柠檬酚的分离鉴定及含量测定研究

采用硅胶色谱柱分离纯化的方法从小槐花药材中分离得到一种黄酮类化合物,根据理化性质及光谱数据鉴定其为异柠檬酚。采用HPLC法对异柠檬酚的含量进行测定,HPLC分析条件如下:色谱柱为Agilent ZORBAX SB-C18(250 mm×4.6 mm,5μm),流动相为甲醇-0.2%磷酸水溶液(70∶30),流速为1.0 mL/min,检测波长为270 nm,柱温为35℃。实验结果表明异柠檬酚在0.011~0.242μg范围与其峰面积呈良好的线性关系;平均回收率为99.76%,RSD为1.42%(n=6),不同采集地的小槐花药材中异柠檬酚的含量存在一定差异。     

反相高效液相色谱法测定石榴皮多酚类物质方法的建立及分析

建立了同时测定石榴皮多酚中绿原酸、表儿茶素、鞣花酸和槲皮素含量的反相高效液相色谱方法。采用色谱柱Hypersil ODS2(250 mm×4.6 mm,5μm),其流动相为乙腈-0.4%磷酸溶液(体积比17∶83),流速为1.0m L/min,检测波长310 nm,柱温为30℃。建立安石榴甙测量方法,色谱柱为Hypersil ODS2(250 mm×4.6 mm,5μm);流动相为甲醇-2%冰醋酸(体积比7∶93);体积流量为1.0 m L/min;检测波长为232 nm;柱温25℃。结果表明:绿原酸、表儿茶素、鞣花酸、槲皮素和安石榴甙在一定浓度范围内与峰面积呈良好的线性关系,其平均回收率分别为100.66%(RSD=2.06%)、100.05%(RSD=0.58%)、100.05%(RSD=0.51%)、99.51%(RSD=1.22%)和99.79%(RSD=0.52%)。此结果说明反相高效液相色谱可用于测定石榴皮多酚类物质。     

精制左旋多巴中L-多巴含量及主要杂质成分的HPLC检测

L-多巴作(L-dopa)为治疗帕金森氏病的主要药物,可以作为食品添加剂开发针对特殊人群的功能性产品。从食药两用植物猫豆种子中纯化的精制L-多巴中通常会含有少量L-酪氨酸等杂质,从而影响精制品作为药物使用。本文建立了一种高效液相色谱方法,可以有效的检测从猫豆中提取的L-多巴主要杂质成分L-酪氨酸(L-tyr)和L-苯丙氨酸(L-phe)的含量。在紫外检测下(λ=260 nm),液相条件为:色谱柱:Dikma Spursil C18柱(250 mm×4.6 mm,5μm);流动相:2%乙酸溶液-甲醇(90∶10);流速:0.8 m L/min;检测波长:260 nm;柱温:室温;能够检测L-多巴和L-苯丙氨酸;在荧光检测下(λex=280 nm,λem=314 nm),液相条件为:色谱柱:Dikma Spursil C18柱(250 mm×4.6mm,5μm);流动相:0.8%甲酸-乙腈(98∶2);进样量:10μL;柱温:室温;能够检测L-多巴与L-酪氨酸。     

大黄药材蒽醌成分的HPLC指纹图谱研究

以大黄酚为参照物,利用高效液相色谱梯度洗脱,测定了10批大黄样品,建立以大黄药材蒽醌及衍生物成分为特征的指纹图谱,色谱柱为YMC-ODS-AQC18柱(250 mm×4.6 mm,5μm);流动相:乙腈(A)-0.2%磷酸水(B),检测波长270 nm,柱温25℃,流速1.0 mL/min,通过高压液相指纹色谱分析,鉴定了13个色谱峰的化学成分,找出24个共有峰,相似度均大于0.92。本文所建立的方法可作为大黄药材质量控制。     

High performance liquid chromatographic method for the determination of cetirizine and ambroxol in human plasma and urine--a boxcar approach

A column switching high performance liquid chromatographic method with estimable sensitivity and accuracy was developed for the determination of cetirizine and ambroxol in human plasma using nebivolol as the internal standard. Plasma samples were prepared by liquid-liquid extraction in methylene chloride and a mixture of diethylether (80:20, v/v). The extracted samples were injected into a multifunctional clean-up column Supelcosil LCABZ (50 mm × 4.6 mm, 5 μm particle size) using mobile phase 1 comprising acetonitrile-phosphate buffer (pH 3.5; 20 mM) (20:80, v/v). The eluate of cetirizine and ambroxol were separated to an analytical Kromasil C(8) micro bore column (50 mm × 0.3 mm, 5 μm particle size) via a column switching device. A Kromasil C(18) analytical column (250 mm × 2.1 mm, 5 μm particle size) was used as a separation column. Mobile phase 2 consisting acetonitrile-triethylamine (0.5%) in phosphate buffer (pH 3.5; 20mM) (55:45, v/v) was used for the compound elution. The eluents were detected at 230 nm with photodiode array detector. An aliquot of 150 μl of plasma sample was introduced into the pretreatment column via the auto sampler using mobile phase 1 at a flow rate of 0.5 ml/min, column switching valve being positioned at A. The pretreatment column retained cetirizine, ambroxol and nebivolol (IS) in the column leaving the residual proteins of plasma eluted in void volume and drained out. The switching valve was shifted to position B at 7.5 min. Cetirizine, ambroxol and IS were eluted from the pretreatment column between 7. 5 and 11.5 min and introduced to the concentration column. Finally, cetirizine, ambroxol and IS were introduced to the separation column by switching valve using mobile phase 2 at a flow rate of 0.4 ml/min. During the analysis the pretreatment column was washed for the next analysis and resume to the position A. The total run time was 25 min for a sample. The procedure was repeated for urine analysis also. The method was linear from 2 to 450 ng/ml and 7-300 ng/ml for cetirizine and ambroxol respectively in plasma and 1-500 ng/ml and 5-400 ng/ml, respectively for cetirizine and ambroxol in urine. Intra-day and inter-day precision of cetirizine and ambroxol was below 15% in terms of coefficient of variation and accuracy of cetirizine and ambroxol was ranged from 94 to 101.6% and 91.1 to 100.2%, respectively. The method demonstrated high sensitivity and selectivity and therefore, applied to evaluate pharmacokinetics of cetirizine and ambroxol in healthy human volunteer after a single oral administration. Urine samples obtained from healthy human volunteers and clinical subjects with renal impairment have also been analyzed by the method to compare the elimination pattern. The method was precise and accurate for the estimation of cetirizine and ambroxol both in blood and in urine.     

Simultaneous determination of cefdinir and cefixime in human plasma by RP-HPLC/UV detection method: Method development, optimization, validation, and its application to a pharmacokinetic study

A novel isocratic reversed-phase high performance liquid-chromatography/ultraviolet detection method for simultaneous determination of cefdinir and cefixime in human plasma was developed and validated after optimization of various chromatographic conditions and other experimental parameters. Sample preparation based on a simple extraction procedure consisting of deproteination and extraction with 3 parts of 6% trichloroacetic acid aqueous solution followed by volume make up with the aqueous component of the mobile phase obtained best recoveries of the two analytes. Samples were separated on a Supelco Discovery HS C(18) (150 mm × 4.6 mm, 5 μm) analytical column protected by a Perkin Elmer C(18) (30 mm × 4.6 mm, 10 μm) guard cartridge. The mobile phase, methanol/acetonitrile (50/50, v/v):0.05% trifluoroacetic acid (19:81, v/v), operated at 50°C column oven temperature was pumped at a flow rate of 2.0 mL min(-1) and the column eluents were monitored at a wavelength of 285 nm. When Sample was injected into the Perkin Elmer high performance liquid-chromatography system through Rheodyne manual (or auto-sampler) injector equipped with 20 μL loop, separation was achieved within 4 min. The present method demonstrated acceptable values for selectivity, linearity within the expected concentration range (0.004-5.0 μg mL(-1); r(2)>0.999 for both analytes), recovery (>95% for cefdinir and >96% for cefixime), precision (%RSD<2.0 for cefdinir and <2.2 for cefixime), sensitivity (limit of detection: 1 ng mL(-1) and lower limit of quantification: 4 ng mL(-1) for both analytes), stability of solutions, and robustness. The method was efficiently applied to a pharmacokinetic study in healthy volunteers.     

Forensic analysis of eleven cyclic antidepressants in human biological samples using a new reversed-phase chromatographic column of 2 μm porous microspherical silica gel

A high-performance liquid chromatographic method has been developed for the forensic analysis of eleven frequently used cyclic antidepressant drugs (ADSs) (amitriptyline, amoxapine, clomipramine, desipramine, dosulepine, doxepin, imipramine, maprotiline, melitracen, mianserine and nortriptyline) using a recently developed reversed-phase column with 2 μm particles for the analysis of biological samples. The separation was carried out using two different C₈ reversed-phase columns (column 1: 100 mm × 4.6 mm I.D., particle size 2 μm, TSK gel Super-Octyl; column 2: 100 mm × 4.6 mm I.D., particle size 5 μm, Hypersil MOS-C₈) for comparison. The mobile phase was composed of methanol-20 mM KH₂PO₄ (pH 7) (60:40, v/v) and the flow-rate was 0.6 ml/min for both columns. The absorbance of the eluent was monitored at 254 nm. When the eleven drugs were determined, the sensitivity with the 2 μm particles was about five times greater than with the 5 μm particles. Retention times on column 1 were shorter than those on column 2. These results show that the new ODS column packing with a particle size of 2 μm gives higher sensitivity and a shorter analysis time than the conventional ODS column packing when applied to the analysis of biological samples.     

Chiral assay of omeprazole and metabolites and its application to a pharmacokinetics related to CYP2C19 genotypes

Studies investigating the relationship between CYP2C19 genotype and the stereoselective metabolism of omeprazole have not been reported. In the present study, we developed a simple and sensitive analytical method based on column switching reversed phase high-performance liquid chromatography (HPLC) with UV detection to determine the concentrations of (R)- and (S)-omeprazole and of its principal metabolites, (R)- and (S)-5-hydroxyomeprazole, and the non-chiral, omeprazole sulfone, in human plasma. Sample preparation involved liquid-liquid extraction with diethyl ether:dichloromethane (60:40, v/v) followed by clean-up on a TSK BSA-ODS/S column (5 μm, 10 mm × 4.6mm i.d.) using phosphate buffer:acetonitrile (97:3, v/v, pH 6.4). After column switching, separation was performed on a Shiseido CD-ph chiral column (5 μm, 150 mm × 4.6mm i.d.) using phosphate buffer:methanol (45:55, v/v, pH 5.0) as mobile phase. The limit of quantitation (LOQ) was 5 ng/mL for all analytes with intra- and inter-day precisions (as coefficient of variation) of <9.5% and <9.6%, respectively for all analytes. The present method was successfully applied to a chiral pharmacokinetic study of omeprazole in human volunteers with different CYP2C19 genotypes. The results show that the formation of (R)-5-hydroxyomeprazole gives the best correlation with CYP2C19 genotype.     

Enantioselective determination of selfotel in human urine by high-performance liquid chromatography on a chiral stationary phase after derivatization with 9-fluorenylmethyl chloroformate

An analytical method for the enantioselective determination of selfotel in human urine has been developed and validated. The method is based on high-performance liquid chromatography and utilizes CGS 20005 (a selfotel analog) as the internal standard. Urine samples were derivatized in situ with o-phthalic dicarboxaldehyde–3-mercaptopropionic acid and 9-fluorenylmethyl chloroformate (FMOC). Chromatographic separations of the FMOC derivatives of selfotel enantiomers and the internal standard were achieved using a column switching system consisting of an Inertsil ODS-2 column (75×4.6 mm I.D., 5 μm) and a Chiralcel OD-R column (250×4.6 mm I.D., 10 μm). The composition of the mobile phase was acetonitrile–0.1 M phosphate buffer, pH 2.50 (35:65) for the Inertsil ODS-2 column and acetonitrile–0.1 M phosphate buffer, pH 2.00 (35:65) for the Chiralcel OD-R column. The analytes were monitored using fluorescence detection at an excitation wavelength of 262 nm and an emission wavelength of 314 nm. The limit of quantification (LOQ) for this method is 0.25 μg/ml for each selfotel enantiomer. The method was successfully utilized to determine preliminary selfotel stereospecific pharmacokinetics.     

Enantioselective determination of selfotel in human urine by high-performance liquid chromatography on a chiral stationary phase after derivatization with 9-fluorenylmethyl chloroformate

An analytical method for the enantioselective determination of selfotel in human urine has been developed and validated. The method is based on high-performance liquid chromatography and utilizes CGS 20005 (a selfotel analog) as the internal standard. Urine samples were derivatized in situ with o-phthalic dicarboxaldehyde–3-mercaptopropionic acid and 9-fluorenylmethyl chloroformate (FMOC). Chromatographic separations of the FMOC derivatives of selfotel enantiomers and the internal standard were achieved using a column switching system consisting of an Inertsil ODS-2 column (75×4.6 mm I.D., 5 μm) and a Chiralcel OD-R column (250×4.6 mm I.D., 10 μm). The composition of the mobile phase was acetonitrile–0.1 M phosphate buffer, pH 2.50 (35:65) for the Inertsil ODS-2 column and acetonitrile–0.1 M phosphate buffer, pH 2.00 (35:65) for the Chiralcel OD-R column. The analytes were monitored using fluorescence detection at an excitation wavelength of 262 nm and an emission wavelength of 314 nm. The limit of quantification (LOQ) for this method is 0.25 μg/ml for each selfotel enantiomer. The method was successfully utilized to determine preliminary selfotel stereospecific pharmacokinetics.     

Narrowbore high-performance liquid chromatography for the simultaneous determination of sildenafil and its metabolite UK-103,320 in human plasma using column switching

A fully automated narrowbore high-performance liquid chromatography method with column switching was developed for the simultaneous determination of sildenafil and its active metabolite UK-103,320 in human plasma samples without pre-purification. Diluted plasma sample (100 μl) was directly introduced onto a Capcell Pak MF Ph-1 column (20×4 mm I.D.) where primary separation occurred to remove proteins and concentrate target substances using 15% acetonitrile in 20 mM phosphate solution (pH 7). The drug molecules eluted from the MF Ph-1 column were focused in an intermediate column (35×2 mm I.D.) by a valve switching step. The substances enriched in the intermediate column were eluted and separated on a phenyl-hexyl column (100×2 mm I.D.) using 36% acetonitrile in 10 mM phosphate solution (pH 4.5) when the valve status was switched back. The method showed excellent sensitivity (detection limit of 10 ng/ml), good precision (RSD≤2.3%) and accuracy (bias: ±2.0%) and speed (total analysis time 17 min). The response was linear (r²≥0.999) over the concentration range 10–1000 ng/ml.     

HPLC法测定杨梅叶中杨梅苷的含量

目的:建立HPLC法测定杨梅叶中杨梅苷含量的方法。方法:采用Diamonsil C18(150 mm×4.6 mm,5μm)柱,流动相乙腈-0.1%磷酸水溶液梯度洗脱,流速1.0 mL/min,检测波长358 nm,柱温30℃。结果:杨梅苷在0.088-0.880 mg/mL内与峰面积呈良好线性关系,A=36113C-401.56,r=0.9994;平均回收率为102.4%,RSD=1.9%(n=9)。测得杨梅叶中杨梅苷含量为1.43%。结论:该测定方法准确,可靠,对于杨梅的进一步开发利用具有重要的参考意义。     

Simultaneous determination of olanzapine,clozapine and demethylated metabolites in serum by on-line column-switching high-performance liquid chromatography

An automated method for simultaneous routine quantification of the antipsychotic drugs clozapine, olanzapine and their demethylated metabolites is described. The method included adsorption on a cyanopropyl (CPS) coated clean-up column (10 μm; 10×2.0 mm I.D.), washing off interfering serum constituents to waste, and separation on C18 ODS Hypersil reversed phase material (5 μm; 250×4.6 mm I.D.) using acetonitrile–water–tetramethylethylenediamine (37:62.6:0.4, v/v/v) adjusted to pH 6.5 with concentrated acetic acid. UV-detection was performed at 254 nm. The limit of quantification was 10–20 ng/ml. Relative day to day standard variations ranged between 4.5 and 13.5%. The method is suitable for routine monitoring of olanzapine and clozapine including their demethylated metabolites.     

HPLC法同时测定草苁蓉中草苁蓉纳拉苷和草苁蓉苷B

为建立高效液相色谱法同时测定草苁蓉干燥全草中草苁蓉纳拉苷和草苁蓉苷B的含量的分析方法,采用色谱柱:Klimail 100-5 C₁₈柱(250 mm×4.6 mm,5μm);流动相:以乙腈为流动相A,以0.5%甲酸水溶液为流动相B,梯度洗脱条件:0~12 min,15%A;12~30 min,15%~20%A;30~40 min,20%~25%A;40~45 min,25%~30%A;45~60 min,30%~100%A;流速:1.0 mL·min^-1;检测波长:260 nm;柱温:30℃;进样量:20μL。得到草苁蓉纳拉苷的线性范围为4.688~150μg·mL^-1(R²=0.999 5);草苁蓉苷B的线性范围为3.438~110μg·mL^-1(R²=0.999 1);平均回收率分别为97.86%、96.55%;RSD分别为1.01、1.23(n=9)。本研究利用高效液相色谱法建立了同时测定草苁蓉全草中草苁蓉纳拉苷和草苁蓉苷B两种组分的方法。方法学的验证结果证明,该方法简便、快捷,重现性好,可以用于草苁蓉中草苁蓉纳拉苷和草苁蓉苷B两种组分的含量测定。